Anbio Biotechnology (NASDAQ:NNNN) Trading 8.6% Higher – Here’s Why

Shares of Anbio Biotechnology (NASDAQ:NNNN) traded up 8.6% during mid-day trading on Thursday . The company traded as high as $26.77 and last traded at $25.00. 24,396 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 64,964 shares. The stock had previously closed at $23.03.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings began coverage on Anbio Biotechnology in a research note on Monday, January 26th. They issued a “sell (d+)” rating for the company. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Anbio Biotechnology Trading Up 10.7%

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.